Skip to main content
. 2020 Jun 23;10:10161. doi: 10.1038/s41598-020-67052-z

Table 2.

Statistical data for tumor patient cohort.

N MSI-H MSS
N 100 (100%) 49 (49%) 51 (51%)
UICC stage
II 59 (59%) 33 (33%) 26 (26%)
III 41 (41%) 16 (16%) 25 (25%)
T category
T1 0 (0%) 0 (0%) 0 (0%)
T2 4 (4%) 1 (1%) 3 (3%)
T3 81 (81%) 42 (42%) 39 (39%)
T4 15 (15%) 6 (6%) 9 (9%)
N category
N0 59 (59%) 32 (32%) 27 (27%)
N1 21 (21%) 7 (7%) 14 (14%)
N2 19 (19%) 9 (9%) 10 (10%)
NX 1 (1%) 1 (1%) 0 (0%)
M category
M0 100 (100%) 49 (49%) 51 (51%)
sex
male 39 (39%) 10 (10%) 29 (29%)
female 61 (61%) 39 (39%) 22 (22%)
localization
Cecum (C18.0) 20 (20%) 13 (13%) 7 (7%)
acending colon (C18.2) 26 (26%) 18 (18%) 8 (8%)
right colonic flexure (C18.3) 7 (7%) 3 (3%) 4 (4%)
transverse colon(C18.4) 11 (11%) 7 (7%) 4 (4%)
left colonic flexure (C18.5) 7 (7%) 2 (2%) 5 (5%)
descending colon (C18.6) 6 (6%) 2 (2%) 4 (4%)
sigmoidic colon (C18.7) 23 (23%) 4 (4%) 19 (19%)
Median Age 78 79 74